4
Changes in Ownership
Protagonist Therapeutics, Inc Filed Acc 0001209191-18-019253
Chief Scientific Officer sold 3,500 shares at $21.29 ($74,500)
- Chief Scientific Officer acquired 3,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Liu David Y · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-03-12 | Exercise or conversion : show line 1 in the form | +3,500 | $4.21 | $14,735 | 18,528 | D |
| 2018-03-12 | Sale : show line 2 in the form | −3,500 | $21.29 | $74,500 | 15,028 | D |
| Open-market sales · 3,500 sh · avg $21.29 · $74,500 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-03-12 | Exercise or conversion : show line 3 in the form Employee Stock Option (right to buy) | −3,500 | 35,331 | D |
Loading xslF345X03/doc4.xml…